|1.||Chen, Yuanzhong: 1 article (01/2015)|
|2.||Ouyang, Shou: 1 article (01/2015)|
|3.||Huang, Weifeng: 1 article (01/2015)|
|4.||Wu, Yong: 1 article (01/2015)|
|5.||Lu, Chunjing: 1 article (01/2015)|
|6.||Cotman, Carl W: 1 article (05/2014)|
|7.||Green, Kim N: 1 article (05/2014)|
|8.||Berchtold, Nicole C: 1 article (05/2014)|
|9.||Rice, Rachel A: 1 article (05/2014)|
01/01/2015 - "These results indicate that mibefradil and NNC-55-0396 regulate proliferation and apoptosis in T-type Ca(2+) channel expressing leukemia cell lines and suggest a potential therapeutic target for leukemia."
01/01/2015 - "We show that leukemia cell lines exhibited reduced cell growth when treated with T-type Ca(2+) channel inhibitors, mibefradil and NNC-55-0396 in a concentration-dependent manner. "
01/01/2015 - "T-type calcium channel antagonists, mibefradil and NNC-55-0396 inhibit cell proliferation and induce cell apoptosis in leukemia cell lines."
|2.||Alzheimer Disease (Alzheimer's Disease)
05/01/2014 - "Downregulating T-type calcium channels in N2a cells and the 3xTg-AD mouse model of Alzheimer's disease, by way of pharmacologic inhibition with NNC-55-0396, results in a rapid increase in amyloid beta production via reductions in non-amyloidogenic processing, whereas genetic overexpression of the channel in human embryonic kidney cells expressing amyloid precursor protein produces complementary effects. "
|1.||T-Type Calcium Channels (T-Type Calcium Channel)
|3.||Amyloid (Amyloid Fibrils)